scispace - formally typeset
L

Luigi Naldini

Researcher at Vita-Salute San Raffaele University

Publications -  370
Citations -  59320

Luigi Naldini is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Genetic enhancement & Viral vector. The author has an hindex of 108, co-authored 345 publications receiving 55080 citations. Previous affiliations of Luigi Naldini include Università telematica San Raffaele & Sangamo BioSciences.

Papers
More filters
Journal ArticleDOI

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells.

TL;DR: TEM cells may account for the proangiogenic activity of bone marrow–derived cells in tumors, may represent a new target for drug development and may provide the means for selective gene delivery and targeted inhibition of tumor angiogenesis.
Journal ArticleDOI

Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells

TL;DR: Blocking angiopoietin-2 (ANG2), a TIE2 ligand and angiogenic factor expressed by activated endothelial cells (ECs), regresses the tumor vasculature and inhibits progression of late-stage, metastatic MMTV-PyMT mammary carcinomas and RIP1-Tag2 pancreatic insulinomas.
Journal ArticleDOI

Cleavage of the Plasma Membrane Na+/Ca2+ Exchanger in Excitotoxicity

TL;DR: It is reported that the major plasma membrane Ca2+ extruding system, the Na+/Ca2+ exchanger (NCX), is cleaved during brain ischemia and in neurons undergoing excitotoxicity, and proteolytic inactivation of NCX-driven neuronal Ca 2+ extrusion is responsible for the delayedexcitotoxic Ca2+, deregulation and neuronal death.
Journal ArticleDOI

Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer

TL;DR: This expression profile enabled stable gene transfer in immunocompetent mice, thus overcoming a major hurdle to successful gene therapy and demonstrating a new paradigm in vector design with applications for genetic engineering and therapeutic gene transfer.
Journal ArticleDOI

Targeted genome editing in human repopulating haematopoietic stem cells

TL;DR: Gene-edited HSCs sustained normal haematopoiesis and gave rise to functional lymphoid cells that possess a selective growth advantage over those carrying disruptive IL2RG mutations, which opens up new avenues for treating SCID-X1 and other diseases.